Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 5 Years

benzinga.com/insights/news/25/06/45782737/heres-how-much-you-would-have-made-owning-halozyme-therapeutics-stock-in-the-last-5-years

Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 5 years by 4.46% on an annualized basis producing an average annual return of 17.65%. Currently, Halozyme Therapeutics has a market capitalization of $6.59 billion.
Buying $1000 In HALO: If ...
Full story…

This story appeared on benzinga.com, 2025-06-04 21:45:19.
The Entire Business World on a Single Page. Free to Use →